Pulmonary Hypertension at Penn
@PennMedPH
Followers
852
Following
504
Media
85
Statuses
291
Follow for updates from the Penn Pulmonary Hypertension Team, a devoted group committed to bettering the lives of our patients.
Philadelphia, PA
Joined August 2020
🚨 Now accepting applications for the 2026–2027 Penn Pulmonary Hypertension Fellowship!.Physicians who’ve completed Cardiology or PCCM fellowships are eligible. Apply by July 11 with CV, cover letter & 3 LORs to: Denice.Susini@pennmedicine.upenn.edu. @ATS_PC @PVRI @ACCP @ISHLT.
1
1
9
Hot off the press - Ambient air pollution exposure and mortality in the @PHAssociation registry. @atscommunity @ATS_PC .
0
2
3
RT @kurt_prins: Nice editorial from Drs. Hemnes and Rischarge on @SashaPrisco's latest paper highlighting areas for future research for the….
0
6
0
RT @ATSBlueEditor: Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study. @atscommunity #PAH. 🔓Open Access….
0
7
0
In a small series of PAH patients treated with sotatercept, withdrawal of selexipag was found to be safe, while discontinuation of parenteral treprostinil was feasible only in a subset of patients.
0
0
5
Highlights:.🔹 Robust curriculum in PH care, imaging, RHC, research & mentorship.🔹 Hands-on experience in PH/PVD diagnosis & management.🔹 Rotations: Adult CHD, HF, transplant & more.🔹 Scholarly activity + dedicated research mentorship.Join us!.
0
0
0
RT @ATS_PC: A great listen on the ERJ podcast where Dr. Marius Hoeper discusses the safety and efficacy of sotater….
0
9
0
Join the @PVRI community call this Friday to hear from our very own @DoctorBreanne and @AlNaamani_N.
Join us for our June PVRI Community Call! We’re excited to welcome guest authors @DoctorBreanne, @AlNaamani_N, and Ricardo Amorim Corrêa as they share insights on:. 🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH.🌍 Morbidity and mortality
0
2
5
RT @ATS_PC: PH-eeling those post- #ATS2025 blues?? Join us for this 🌟 Webinar in just 1 week! @MaryamSanjani @TimLahm @Viniciodjperez @atsc….
0
7
0
Huge congratulations to mentor extraordinaire, Dr. Nadine Al-Naamani, on receiving the ATS Pulmonary Circulation Assembly Mid-Career Research Achievement Award!.A well-deserved honor for her impactful work and leadership in PH research. 👏🎉.#ATS2025 #WomenInMedicine @ATS_PC
0
3
13
Exciting data from Dr. Jasleen Minhas’s #ATS2025 talk on the PHANTOM trial!.• Daily activity time reflects disease severity & outcomes in PAH.• High adherence shows remote monitoring is feasible.• Real-world activity patterns can enhance clinic-based care.#DigitalHealth
0
0
1
Next, our ⭐️ PH fellow, Dr. Oudah, presented @PHAssociation data on HRQoL in PoPH .• PoPH patients had worse HRQoL vs. general population.• Worse HRQoL linked to female sex, higher BMI, unemployment & lower eGFR.Advancing patient-centered care in PH 💪
0
0
0
Days 2 and 3. First up -@DoctorBreanne investigated @PHAssociation data on how insurance type impacts treatment in PAH.🔑 findings .• Insurance type linked to use of combo therapy, Patterns varied by region.• Biggest disparities in younger pts with private insurance.#ATS2025
2
1
8
RT @LungTxptMD: Excited to share a @UCSFHospitals and @CedarsSinai collaboration recently published in @accpchest. How I do it: Best prac….
0
6
0
RT @ATS_PC: Move over hypothalamic-pituitary-adrenal axis, it’s all about the liver-lung axis! Here’s Dr. Nadine Al Naamani sharing her tak….
0
3
0
@PHAssociation And some non conference victories at #ATS2025! Dr. Jasleen Minhas covered ground both in science and on the streets of San Francisco—running the Bay to Breakers this weekend. #BaytoBreakers
0
0
1
RT @BrownPVD: This afternoon’s #ATS2025 session has been wonderful! Our own #CoreyVentetuolo spoke about lessons we’ve learned about EC pla….
0
4
0
RT @ATS_PC: 🌟 Presentation from #DrJasleenMinhas: “ Remote Monitoring of Physical Activity in Randomized Clinical Trial of Anastrozole in P….
0
2
0